Bristol-Myers Squibb Future Growth
Future criteria checks 4/6
Bristol-Myers Squibb's revenue is forecast to decline at 2.6% per annum while its annual earnings are expected to grow at 49% per year. EPS is expected to grow by 46.2% per annum. Return on equity is forecast to be 67.8% in 3 years.
Key information
49.0%
Earnings growth rate
46.2%
EPS growth rate
Pharmaceuticals earnings growth | 23.5% |
Revenue growth rate | -2.6% |
Future return on equity | 67.8% |
Analyst coverage | Good |
Last updated | 09 Sep 2024 |
Recent future growth updates
Recent updates
Bristol-Myers Still A Value Play Despite Appreciating 26.56% From 2024 Lows
Sep 06Bristol-Myers Squibb Company's (NYSE:BMY) Share Price Is Matching Sentiment Around Its Revenues
Aug 15Bristol-Myers Squibb: A Potential Comeback In Healthcare
Aug 06Bristol-Myers Squibb: Q2 Earnings Look Like An Inflection Point
Jul 27Bristol Myers Squibb: The More It Drops, The More I Buy
Jul 16Is Bristol-Myers Squibb (NYSE:BMY) A Risky Investment?
Jun 13Bristol Myers: Quality Fundamentals Suppressed By Interest Rates
Jun 09Bristol-Myers Squibb: Looking Beyond The One-Time Quarterly Loss
Jun 03Bristol-Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity
May 23Bristol-Myers Squibb: A Lost Decade?
May 03Lacklustre Performance Is Driving Bristol-Myers Squibb Company's (NYSE:BMY) Low P/S
Apr 29Is Bristol Myers Squibb A Buy At These Bottom Levels?
Apr 22Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
Apr 12Bristol-Myers Squibb Is A Speculative Buy On Price Action (Technical Analysis)
Apr 02Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60
Mar 21Bristol-Myers Squibb Is Not A Buy For Me
Mar 19Bristol-Myers Squibb: Compelling Value From The New Products Portfolio And 4.5% Yield
Mar 07Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60
Mar 07We Think Bristol-Myers Squibb's (NYSE:BMY) Healthy Earnings Might Be Conservative
Feb 20Bristol-Myers Squibb Company (NYSE:BMY) Just Released Its Annual Results And Analysts Are Updating Their Estimates
Feb 06Bristol-Myers Squibb: Massive Discount Spells Opportunity
Feb 04Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 44,069 | 11,192 | 12,689 | 13,283 | 21 |
12/31/2025 | 46,531 | 11,413 | 13,581 | 14,438 | 23 |
12/31/2024 | 46,758 | -3,289 | 15,574 | 9,699 | 23 |
6/30/2024 | 46,509 | -6,541 | 12,945 | 14,163 | N/A |
3/31/2024 | 45,534 | -6,148 | 12,509 | 13,724 | N/A |
12/31/2023 | 45,006 | 8,025 | 12,651 | 13,860 | N/A |
9/30/2023 | 44,935 | 8,285 | 11,468 | 12,914 | N/A |
6/30/2023 | 45,187 | 7,963 | 10,499 | 11,850 | N/A |
3/31/2023 | 45,848 | 7,311 | 10,860 | 12,224 | N/A |
12/31/2022 | 46,159 | 6,327 | 11,948 | 13,066 | N/A |
9/30/2022 | 46,738 | 6,677 | 12,946 | 13,817 | N/A |
6/30/2022 | 47,144 | 6,617 | 14,502 | 15,396 | N/A |
3/31/2022 | 46,960 | 6,251 | 15,347 | 16,195 | N/A |
12/31/2021 | 46,385 | 6,994 | 15,234 | 16,207 | N/A |
9/30/2021 | 45,468 | -5,405 | 14,569 | 15,505 | N/A |
6/30/2021 | 44,384 | -5,079 | 11,687 | 12,506 | N/A |
3/31/2021 | 42,810 | -6,219 | 13,215 | 13,939 | N/A |
12/31/2020 | 42,518 | -9,015 | 13,299 | 14,052 | N/A |
9/30/2020 | 39,395 | -44 | 12,157 | 12,878 | N/A |
6/30/2020 | 34,862 | -563 | 12,409 | 13,167 | N/A |
3/31/2020 | 31,006 | 954 | 9,939 | 10,757 | N/A |
12/31/2019 | 26,145 | 3,439 | 7,374 | 8,210 | N/A |
9/30/2019 | 24,173 | 5,655 | 7,583 | 8,458 | N/A |
6/30/2019 | 23,857 | 6,203 | 6,272 | 7,181 | N/A |
3/31/2019 | 23,288 | 5,144 | 5,239 | 6,155 | N/A |
12/31/2018 | 22,561 | 4,920 | 6,115 | 7,066 | N/A |
9/30/2018 | 22,037 | 1,432 | 3,713 | 4,628 | N/A |
6/30/2018 | 21,600 | 376 | 4,109 | 5,062 | N/A |
3/31/2018 | 21,040 | 919 | N/A | 5,589 | N/A |
12/31/2017 | 20,776 | 1,007 | N/A | 5,275 | N/A |
9/30/2017 | 20,570 | 4,229 | N/A | 5,601 | N/A |
6/30/2017 | 20,238 | 4,586 | N/A | 5,292 | N/A |
3/31/2017 | 19,965 | 4,836 | N/A | 4,147 | N/A |
12/31/2016 | 19,427 | 4,457 | N/A | 3,058 | N/A |
9/30/2016 | 18,471 | 3,366 | N/A | 2,226 | N/A |
6/30/2016 | 17,618 | 2,870 | N/A | 1,346 | N/A |
3/31/2016 | 16,910 | 1,574 | N/A | 978 | N/A |
12/31/2015 | 16,560 | 1,565 | N/A | 2,105 | N/A |
9/30/2015 | 16,531 | 1,775 | N/A | 1,793 | N/A |
6/30/2015 | 16,383 | 1,790 | N/A | 2,172 | N/A |
3/31/2015 | 16,109 | 2,253 | N/A | 3,157 | N/A |
12/31/2014 | 15,879 | 2,004 | N/A | 3,148 | N/A |
9/30/2014 | 16,062 | 2,717 | N/A | 3,986 | N/A |
6/30/2014 | 16,206 | 2,688 | N/A | 4,136 | N/A |
3/31/2014 | 16,365 | 2,891 | N/A | 4,590 | N/A |
12/31/2013 | 16,385 | 2,563 | N/A | 3,545 | N/A |
9/30/2013 | 16,135 | 2,762 | N/A | 2,971 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BMY is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Earnings vs Market: BMY is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: BMY is expected to become profitable in the next 3 years.
Revenue vs Market: BMY's revenue is expected to decline over the next 3 years (-2.6% per year).
High Growth Revenue: BMY's revenue is forecast to decline over the next 3 years (-2.6% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BMY's Return on Equity is forecast to be very high in 3 years time (67.8%).